<DOC>
	<DOC>NCT00348491</DOC>
	<brief_summary>This study will assess the safety and efficacy of lumiracoxib 400 mg in relieving moderate to severe post-dental surgery pain, compared to both placebo and celecoxib 400 mg.</brief_summary>
	<brief_title>Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Requiring extraction of two or more partially impacted or fully bony impacted third molars. At least one of the extractions must be mandibular Moderate to severe postdental surgery pain intensity (as rated by the patient on the categorical pain intensity scale within five hours of surgery Evidence or history of any cardiac and cerebral thrombotic/ ischemic diseases and/ or events Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Dental surgery</keyword>
	<keyword>acute pain</keyword>
	<keyword>lumiracoxib</keyword>
	<keyword>celecoxib</keyword>
	<keyword>Moderate to severe pain following dental surgery</keyword>
</DOC>